ADPKD gene therapy startup Estuary raises $103M to enter clinic
Estuary Biotherapeutics raised $103 million to advance two locally delivered AAV gene therapies for ADPKD toward first-in-human testing.
By Dr. A. Nikhil Krishnan, MBBS
·
Oct 16, 2026
·
5 min read